JAMIE MILLER: Open Payments
NPI 1184646630 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,038 in 161 payments from 20 companies in 2025. Trend: 2023 $4,040 · 2024 $3,036 · 2025 $3,038
Food & beverage: $3,026Travel & lodging: $12
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 19 | $563 |
| Mannkind Corporation | 23 | $418 |
| Novo Nordisk Inc | 21 | $349 |
| Corcept Therapeutics | 14 | $304 |
| Insulet Corporation | 19 | $264 |
| BETA BIONICS, INC. | 11 | $220 |
| Tandem Diabetes Care, Inc. | 9 | $134 |
| Novartis Pharmaceuticals Corporation | 7 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
Products named: MINIMED 780G, AFREZZA, Korlym, Omnipod, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, LEQVIO, Ozempic.
Industry payments across KY — which companies pay providers there.
